Albireo Pharma Inc Bennfentes tulajdonlás
Mi az Albireo Pharma Inc Bennfentes tulajdonlás?
A Bennfentes tulajdonlás az Albireo Pharma Inc - 0.48%
Mi a Bennfentes tulajdonlás meghatározása?
A bennfentes tulajdonjog kiszámítása a bennfentesek tulajdonában lévő részvények (részvényesek, akik a vállalat több mint 5% -át, vagy a vállalat tisztségviselőjét vagy igazgatóját birtokolják) teljes létszámával, osztva a teljes részvénykivonással.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Bennfentes tulajdonlás a Health Care szektor a NASDAQ-on cégekben a Albireo Pharma Inc -hoz képest
Mit csinál Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
bennfentes tulajdonlás -hoz hasonló cégek Albireo Pharma Inc
- The Interpublic of Companies nak Bennfentes tulajdonlás 0.48% van
- Brookfield Business nak Bennfentes tulajdonlás 0.48% van
- New Residential Investment Corp nak Bennfentes tulajdonlás 0.48% van
- Qorvo Dl ,0001 nak Bennfentes tulajdonlás 0.48% van
- Qorvo Inc nak Bennfentes tulajdonlás 0.48% van
- Definity nak Bennfentes tulajdonlás 0.48% van
- Albireo Pharma Inc nak Bennfentes tulajdonlás 0.48% van
- EQT nak Bennfentes tulajdonlás 0.48% van
- Northern 2 VCT PLC nak Bennfentes tulajdonlás 0.49% van
- Ascot Resources nak Bennfentes tulajdonlás 0.49% van
- Ascot Resources nak Bennfentes tulajdonlás 0.49% van
- Olin nak Bennfentes tulajdonlás 0.49% van
- Editas Medicine Inc nak Bennfentes tulajdonlás 0.49% van